25 high-performance-computing-postdoc research jobs at University of Newcastle in United Kingdom
Sort by
Refine Your Search
-
and consortium to share information and data to optimise and validate models to ensure high efficiency and performance of the overall integrated system • Manufacture membrane electrode assemblies
-
the assay and development of the bioinformatic pipelines. In addition, they will lead on the processing of samples, transfer of samples/data to/from the commercial company and performing independent
-
flood modelling and urban infrastructure teams to integrate ML outputs into broader flood risk assessment frameworks Continuously evaluate model performance and improve its accuracy and efficiency
-
and impact related to two EPSRC funded projects: ResTOrES (Resilience Toolkit for Offshore Energy Systems) and RENEW (Climate Resilient Heat Electrification for Net-Zero Emission Whole Energy). The
-
real difference for patients living with this condition. With a focus on high-impact publications and grant applications, the post-doc will have the opportunity to shape their own research agenda while
-
an integrated programme of medicinal chemistry and further screening, PTSuppress will optimise these lead compounds and repurpose already approved drugs. Ultimately, we will validate the best compounds/drugs
-
, the flagship programme of the Newcastle Health Research Partnership. In addition to the Newcastle PSRC, the postholder will have an academic home at the Newcastle University Population Health Sciences Institute
-
rapidly acquire new skills Detailed knowledge of statistical methods Likelihood of advanced skills directly related to biostatistics High level of analytical and problem-solving capability Ability
-
Patterson Foundation and is aimed at generating pilot data to support further funding applications. We are looking for a motivated researcher to join our group to perform transcriptomics and functional assays
-
well-characterised tumour models, the research will identify and validate new drug targets that are specifically lethal to tumour cells lacking SMARCB1. The ultimate goal is to generate high-quality